Jan 30, 2019
FDA approves first generic Advair Diskus
Jan 24, 2019
Visiongain Report Looks at Opportunities within the $47bn Asthma & COPD Market
Jan 16, 2019
Active Pharmaceutical Ingredients Market Report Forecast High Growth By 2025
Jan 14, 2019
Global Transdermal Drug Delivery System Market 2018-2023: Opportunities with Collaborations Between Pharmaceutical Companies and Drug Delivery Firms
Jan 14, 2019
World Autoinjectors Market 2018-2024: Market is Estimated to Witness a CAGR of 17.1% - Key Manufacturers are Concentrating on Innovative Marketing Tactics
Jan 14, 2019
The transdermal drug delivery systems market is projected to grow at a CAGR of 4.5%
Jan 08, 2019
Transdermal Drug Delivery Systems Market Worth $7.1 Billion by 2023 - Exclusive Report by MarketsandMarkets(TM)
Dec 20, 2018
Mylan to Present at the 37th Annual J.P. Morgan Healthcare Conference
Dec 17, 2018
Launch of Generic Lialda® Delayed-Release Tablets Expands Mylan's Gastroenterology Product Offering
Dec 17, 2018
Mylan Adds First Generic for Canasa® Rectal Suppository to Growing Gastroenterology Portfolio
Dec 13, 2018
Sanofi's Formulation Patents on Multibillion-Dollar Lantus® are Invalidated by U.S. Patent and Trademark Office via IPR, Announces Mylan
Dec 12, 2018
Global Transdermal Drug Delivery System Market to 2023 - Patches is Expected to Hold its Dominant Position in the Market
Dec 05, 2018
Generic Oncology Drugs Market Holds Promising Opportunities for Small Molecule Modalities - Persistence Market Research
Dec 04, 2018
Global Transdermal Drug Delivery System Market is projected to display a high growth represented by a CAGR of 12.18% during 2018 - 2023
Dec 04, 2018
Global Opioids Drug Market Forecast 2019-2027
Dec 04, 2018
Global $1.04 Billion Anti-Malarial Drugs Market to 2027 - Focus on Anti-Malarial Activity Tissue Schizonticides, Blood Schizonticides, Gametocytocides & Sporontocides
Dec 04, 2018
Mylan Expands Gastroenterology Portfolio with Launch of Generic for Prevacid® SoluTab Delayed-Release Orally Disintegrating Tablets
Nov 28, 2018
Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity
Nov 26, 2018
Mylan to Present at Nasdaq's 39th London Investor Conference
Nov 09, 2018
Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI(TM) (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease